Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
39
|
pubmed:dateCreated |
1978-12-20
|
pubmed:language |
pol
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0032-3756
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
25
|
pubmed:volume |
33
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1547-8
|
pubmed:dateRevised |
2008-6-20
|
pubmed:meshHeading |
pubmed-meshheading:704457-Acetamides,
pubmed-meshheading:704457-Amebicides,
pubmed-meshheading:704457-Amines,
pubmed-meshheading:704457-Benzylamines,
pubmed-meshheading:704457-Drug Evaluation,
pubmed-meshheading:704457-Dysentery, Amebic,
pubmed-meshheading:704457-Entamoebiasis,
pubmed-meshheading:704457-Humans
|
pubmed:year |
1978
|
pubmed:articleTitle |
[Clinical evaluation of a new amebicide, Falmonox].
|
pubmed:publicationType |
Journal Article,
English Abstract
|